Whole genome expression profiling of glucose-dependent insulinotropic peptide (GIP)- and adrenocorticotropin-dependent adrenal hyperplasias reveals novel targets for the study of GIP-dependent Cushing's syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 9, 2006, Pages 3611-3618

  Lampron, Antoine ^a   Bourdeau, Isabelle ^a   Hamet, Pavel ^a   Tremblay, Johanne ^a   Lacroix, André ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; G PROTEIN COUPLED RECEPTOR; GASTRIC INHIBITORY POLYPEPTIDE; HISTONE; PERILIPIN; RETINOID X RECEPTOR ALPHA; RHO GUANINE NUCLEOTIDE BINDING PROTEIN;

ADRENAL HYPERPLASIA; ADRENOCORTICOTROPIN DEPENDENT ADRENAL HYPERPLASIA; ARTICLE; CARCINOGENESIS; CELL SURFACE; CONTROLLED STUDY; CUSHING SYNDROME; DNA MICROARRAY; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTEIN MODIFICATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 33748749269     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-0221     Document Type: Article

References (45)

1. Lacroix A, Bourdeau I 2005 Bilateral adrenal Cushing's syndrome: macronodular adrenal hyperplasia and primary pigmented nodular adrenocortical disease. Endocrinol Metab Clin North Am 34:441-458
2. Fragoso MC, Domenice S, Latronico AC, Martin RM, Pereira MA, Zerbini MC, Lucon AM, Mendonca BB 2003 Cushing's syndrome secondary to adrenocorticotropin- independent macronodular adrenocortical hyperplasia due to activating mutations of GNAS1 gene. J Clin Endocrinol Metab 88:2147-2151
3. Christopoulos S, Bourdeau I, Lacroix A 2005 Clinical and subclinical ACTH-independent macronodular adrenal hyperplasia and aberrant hormone receptors. Horm Res 64:119-131
4. Gicquel C, Bertagna X, Le Bouc Y 1995 Recent advances in the pathogenesis of adrenocortical tumours. Eur J Endocrinol 133:133-144
5. Diaz-Cano SJ, de Miguel M, Blanes A, Tashjian R, Galera H, Wolfe HJ 2000 Clonality as expression of distinctive cell kinetics patterns in nodular hyperplasias and adenomas of the adrenal cortex. Am J Pathol 156:311-319
6. Beuschlein F, Reincke M, Karl M, Travis WD, Jaursch-Hancke C, Abdelhamid S, Chrousos GP, Allolio B 1994 Clonal composition of human adrenocortical neoplasms. Cancer Res 54:4927-4932
7. Lacroix A, Baldacchino V, Bourdeau I, Hamet P, Tremblay J 2004 Cushing's syndrome variants secondary to aberrant hormone receptors. Trends Endocrinol Metab 15:375-382
8. Lacroix A, N'Diaye N, Tremblay J, Hamet P 2001 Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome. Endocr Rev 22:75-110
9. Antonini SR, N'Diaye N, Baldacchino V, Hamet P, Tremblay J, Lacroix A 2004 Analysis of the putative regulatory region of the gastric inhibitory polypeptide receptor gene in food-dependent Cushing's syndrome. J Steroid Biochem Mol Biol 91:171-177
10. Baldacchino V, Oble S, Decarie PO, Bourdeau I, Hamet P, Tremblay J, Lacroix A 2005 The Sp transcription factors are involved in the cellular expression of the human glucose-dependent insulinotropic polypeptide receptor gene and overexpressed in adrenals of patients with Cushing's syndrome. J Mol Endocrinol 35:61-71
11. Mazzuco TL, Chabre O, Sturm N, Feige JJ, Thomas M 2006 Ectopic expression of the gastric inhibitory polypeptide receptor gene is a sufficient genetic event to induce benign adrenocortical tumor in a xenotransplantation model. Endocrinology 147:782-790
12. N'Diaye N, Hamet P, Tremblay J, Boutin JM, Gaboury L, Lacroix A 1999 Asynchronous development of bilateral nodular adrenal hyperplasia in gastric inhibitory polypeptide-dependent Cushing's syndrome. J Clin Endocrinol Metab 84:2616-2622
13. Chabre O, Liakos P, Vivier J, Chaffanjon P, Labat-Moleur F, Martinie M, Bottari SP, Bachelot I, Chambaz EM, Defaye G, Feige JJ 1998 Cushing's syndrome due to a gastric inhibitory polypeptide-dependent adrenal adenoma: insights into hormonal control of adrenocortical tumorigenesis. J Clin Endocrinol Metab 83:3134-3143
14. Doppman JL, Chrousos GP, Papanicolaou DA, Stratakis CA, Alexander HR, Nieman LK 2000 Adrenocorticotropin-independent macronodular adrenal hyperplasia: an uncommon cause of primary adrenal hypercortisolism. Radiology 216:797-802
15. Antonini SR, Baldacchino V, Tremblay J, Hamet P, Lacroix A 2006 Expression of ACTH receptor pathway genes in glucose-dependent insulinotropic peptide (GIP)-dependent Cushing's syndrome. Clin Endocrinol (Oxf) 64:29-36
16. Gerl H, Rohde W, Biering H, Schulz N, Lochs H 2000 Food-dependent Cushing syndrome of long standing with mild clinical features. Dtsch Med Wochenschr 125:1565-1568
17. Mircescu H, Jilwan J, N'Diaye N, Bourdeau I, Tremblay J, Hamet P, Lacroix A 2000 Are ectopic or abnormal membrane hormone receptors frequently present in adrenal Cushing's syndrome? J Clin Endocrinol Metab 85:3531-3536
18. Pan W 2002 A comparative review of statistical methods for discovering differentially expressed genes in replicated microarray experiments. Bioinformatics 18:546-554
19. Tusher VG, Tibshirani R, Chu G 2002 Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98:5116-5121
20. Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, Braisted J, Klapa M, Currier T, Thiagarajan M, Sturn A, Snuffin M, Rezantsev A, Popov D, Ryltsov A, Kostukovich E, Borisovsky I, Liu Z, Vinsavich A, Trush V, Quackenbush J 2003 TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34:374-378
21. Liu G, Loraine AE, Shigeta R, Cline M, Cheng J, Valmeekam V, Sun S, Kulp D, Siani-Rose MA 2003 NetAffx: Affymetrix probesets and annotations. Nucleic Acids Res 31:82-86
22. Masseroli M, Martucci D, Pinciroli F 2004 GFINDer: Genome Function INtegrated Discoverer through dynamic annotation, statistical analysis, and mining. Nucleic Acids Res 32:W293-W300
23. Eisen MB, Spellman PT, Brown PO, Botstein D 1998 Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95:14863-14868
24. Quackenbush J 2002 Microarray data normalization and transformation. Nat Genet 32:S496-S501
25. Bourdeau I, Antonini SR, Lacroix A, Kirschner LS, Matyakhina L, Lorang D, Libutti SK, Stratakis CA 2004 Gene array analysis of macronodular adrenal hyperplasia confirms clinical heterogeneity and identifies several candidate genes as molecular mediators. Oncogene 23:1575-1585
26. Saha PK, Kojima H, Martinez-Botas J, Sunehag AL, Chan L 2004 Metabolic adaptations in the absence of perilipin: increased β-oxidation and decreased hepatic glucose production associated with peripheral insulin resistance but normal glucose tolerance in perilipin-null mice. J Biol Chem 279:35150-35158
27. Steketee K, Ziel-van der Made AC, van der Korput HA, Houtsmuller AB, Trapman JA 2004 Bioinformatics-based functional analysis shows that the specifically androgen-regulated gene SARG contains an active direct repeat androgen response element in the first intron. J Mol Endocrinol 33:477-491
28. Swords FM, Aylwin S, Perry L, Arola J, Grossman AB, Monson JP, Clark AJ 2005 The aberrant expression of the gastric inhibitory polypeptide (GIP) receptor in adrenal hyperplasia: does chronic adrenocorticotropin exposure stimulate up-regulation of GIP receptors in Cushing's disease? J Clin Endocrinol Metab 90:3009-3016
29. Pralong FP, Gomez F, Guillou L, Mosimann F, Franscella S, Gaillard RC 1999 Food-dependent Cushing's syndrome: possible involvement of leptin in cortisol hypersecretion. J Clin Endocrinol Metab 84:3817-3822
30. Bertherat J, Contesse V, Louiset E, Barrande G, Duparc C, Groussin L, Emy P, Bertagna X, Kuhn JM, Vaudry H, Lefebvre H 2005 In vivo and in vitro screening for illegitimate receptors in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome: identification of two cases of gonadotropin/gastric inhibitory polypeptide-dependent hypercortisolism. J Clin Endocrinol Metab 90:1302-1310
31. Yip RG, Wolfe MM 2000 GIP biology and fat metabolism. Life Sci 66:91-103
32. Zweytick D, Athenstaedt K, Daum G 2000 Intracellular lipid particles of eukaryotic cells. Biochim Biophys Acta 1469:101-120
33. Servetnick DA, Brasaemle DL, Gruia-Gray J, Kimmel AR, Wolff J, Londos C 1995 Perilipins are associated with cholesteryl ester droplets in steroidogenic adrenal cortical and Leydig cells. J Biol Chem 270:16970-16973
34. Tansey JT, Sztalryd C, Hlavin EM, Kimmel AR, Londos C 2004 The central role of perilipin A in lipid metabolism and adipocyte lipolysis. IUBMB Life 56:379-385
35. Souza SC, de Vargas LM, Yamamoto MT, Lien P, Franciosa MD, Moss LG, Greenberg AS 1998 Overexpression of perilipin A and B blocks the ability of tumor necrosis factor α to increase lipolysis in 3T3-L1 adipocytes. J Biol Chem 273:24665-24669
36. Zhang HH, Halbleib M, Ahmad F, Manganiello VC, Greenberg AS 2002 Tumor necrosis factor-α stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP. Diabetes 51:2929-2935
37. Lynn FC, Thompson SA, Pospisilik JA, Ehses JA, Hinke SA, Pamir N, McIntosh CH, Pederson RA 2003 A novel pathway for regulation of glucose-dependent insulinotropic polypeptide (GIP) receptor expression in β cells. FASEB J 17:91-93
38. Zhang K, Kniazeva M, Han M, Li W, Yu Z, Yang Z, Li Y, Metzker ML, Allikmets R, Zack DJ, Kakuk LE, Lagali PS, Wong PW, MacDonald IM, Sieving PA, Figueroa DJ, Austin CP, Gould RJ, Ayyagari R, Petrukhin K 2001 A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy. Nat Genet 27:89-93
39. Herzog H 2003 Neuropeptide Y and energy homeostasis: insights from Y receptor knockout models. Eur J Pharmacol 480:21-29
40. Xu Y 2002 Sphingosylphosphorylcholine and lysophosphatidylcholine: G protein-coupled receptors and receptor-mediated signal transduction. Biochim Biophys Acta 1582:81-88
41. Xu CB, Hansen-Schwartz J, Edvinsson L 2004 Sphingosine signaling and atherogenesis. Acta Pharmacol Sin 25:849-854
42. Didsbury J, Weber RF, Bokoch GM, Evans T, Snyderman R 1989 rac, a novel ras-related family of proteins that are botulinum toxin substrates. J Biol Chem 264:16378-16382
43. Roberts AW, Kim C, Zhen L, Lowe JB, Kapur R, Petryniak B, Spaetti A, Pollock JD, Borneo JB, Bradford GB, Atkinson SJ, Dinauer MC, Williams DA 1999 Deficiency of the hematopoietic cell-specific Rho family GTPase Rac2 is characterized by abnormalities in neutrophil function and host defense. Immunity 10:183-196
44. You HJ, Woo CH, Choi EY, Cho SH, Yoo YJ, Kim JH 2005 Roles of Rac and p38 kinase in the activation of cytosolic phospholipase A2 in response to PMA. Biochem J 388(Pt 2):527-535
45. Ehses JA, Casilla VR, Doty T, Pospisilik JA, Winter KD, Demuth HU, Pederson RA, McIntosh CH 2003 Glucose-dependent insulinotropic polypeptide promotes β-(INS-1) cell survival via cyclic adenosine monophosphate- mediated caspase-3 inhibition and regulation of p38 mitogen-activated protein kinase. Endocrinology 144:4433-4445